gSpiriva Delivers First Mover Advantage In US, Lupin Plans Europe Launch

Lucentis Biosimilar Filing Seen In FY25

 
• By Vibha Ravi
  
Growth Upward Trajectory
Lupin - On A Growth Trajectory • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip